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The Type III Secretion (T3S) system is a system utilized by many 
pathogenic bacteria to inject proteins into host cells during an infection. Effector 
proteins enter the host cell by passing through the proteinaceous T3S translocon, 
which forms a pore on the host cell membrane. Pseudomonas aeruginosa is an 
opportunistic pathogen that utilizes the T3S system, and very little is known 
about how the P. aeruginosa translocon forms.  
The proteins PopB and PopD are believed to assemble into the P. 
aeruginosa translocon. A pore-forming heterocomplex of PopB and PopD has 
been reconstituted in model membranes, however this heterocomplex has not 
been assessed in its relation to the translocon formed on the host cell. The 
interaction of this heterocomplex with other T3S system components was 
measured to determine if this complex acts similarly to the translocon. Initial 
assays that can be used to compare the molecular weight of the translocon 
isolated from eukaryotic cells after P. aeruginosa contact to the calculated 
molecular weight of the heterocomplex were developed as well. This study 
v 
provides insight into how the PopB:PopD heterocomplex formed in model 
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1.1 Pseudomonas aeruginosa 
Pseudomonas aeruginosa is a ubiquitous Gram-negative opportunistic 
pathogen that is one of the leading causes of nosocomial infections (Vincent, 
2003). This bacterium colonizes a wide variety of niches including soil, plants, 
and animals. In humans, P. aeruginosa is found as a part of the skin flora (Cogen 
et al., 2008), however it commonly colonizes the respiratory, urinary, and 
gastrointestinal tracts causing severe infections in immunocompromised patients 
(Carmeli, 1999).   
P. aeruginosa is the leading cause of infections in patients with chronic 
obstructive pulmonary disease, cystic fibrosis, and burns, as well as the number 
one cause of ventilator associated pneumonia; the latter two having mortality 
rates greater than 30% (Vincent, 2003; Oliver et al., 2008). Infections are difficult 
to treat as P. aeruginosa easily acquires antibiotic resistance (Tenover, 2006). 
Furthermore, this pathogen forms biofilms, which can allow development of 
antibiotic resistance up to 1,000 times that of planktonic cells (Hoyle and 
Costerton, 1991).  In fact, biofilms occur in approximately 65% of all human P. 
aeruginosa infections (Filloux and Vallet, 2003; Chicurel, 2000). 
Like other gram-negative pathogens, this bacterium uses the Type III 
Secretion (T3S) system to inject toxins into a host cell. The T3S system is closely 
tied with infection; in fact, immunization with T3S components successfully 
protects animals from P. aeruginosa pneumonia (Lyzak et al., 2000). This system 
2 
is common to many pathogenic bacteria including: Chlamydia species, Shigella 
species, Salmonella species, and Yersinia species (Coburn et al., 2007), and a 
greater understanding of this infection mechanism is necessary to develop 
effective infection therapies.  
1.2 Type III Secretion system 
The T3S system is used to inject toxins directly into the host cell 
cytoplasm. This system utilizes a syringe-like T3S apparatus. The T3S apparatus 
consists of an injectisome that spans both the inner and outer bacterial cell 
membranes, a needle that extends outward from the cell surface, and a protein 
oligomer that forms at the tip of the needle (Fig 1.1). Additionally, translocator 
proteins function to form a pore in the host cell membrane to allow effector 
proteins to pass into the host cell.  
Type III Secretion remains inactive until the bacterium comes in contact 
with a host cell (Mueller, 2005; Matteï et al., 2011). The T3S apparatus is present 
at the bacterial cell surface, and contact between the needle tip and the host cell 
is hypothesized to activate Type III Secretion. Upon T3S activation, translocators 
are first translocated through the needle in a partially folded state, and assemble 
on the target membrane forming the translocon. The translocon is then believed 
to engage with the needle tip, allowing for efficient transport of effectors from the 
bacterial cytosol into the host cell cytosol (Fig 1.2). 
1.3 Injectisome 
The injectisome is a complex of proteins that spans the inner and outer 
membrane of the bacteria (Fig 1.1). The T3S system injectisome closely  
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Figure 1.1. Ysc Family Type III Secretion Apparatus. P. aeruginosa utilizes 
the Ysc family T3S apparatus (Cornelis, 2006), which consists of an injectisome 
spanning the inner and outer bacterial membranes, a 50-80 nm needle that 
extends beyond the cell surface capped by a tip complex that interacts with the 
host cell membrane. Translocator protein effector proteins are secreted through 






Figure 1.2. Translocon Hypothesis in P. aeruginosa T3S apparatus. 
Interaction with a host cell stimulates T3S and the translocators PopB (blue) and 
PopD (red), to be released from their chaperone PcrH (green) in the bacterial 
cytoplasm and be secreted through the needle in a partially unfolded state. The 
translocators insert into the host cell membrane and assemble into the 
translocon. The needle engages with the host cell membrane through the tip 
complex, PcrV (orange). Effectors (black) are secreted through the T3S 





resembles the flagellum (Cornelis, 2006). Based on cryo-EM of purified 
Salmonella T3S apparatuses, the injectisome consists of two rings anchored in 
the bacterial membranes with a hollow channel (~2 nm in diameter) traversing its 
length (Schraidt and Marlovitz, 2011). An ATPase component of the injectisome 
likely aids in unfolding secreted proteins to enable passage through the narrow 
channel (Akeda and Galán, 2005). The T3S needle extends from the injectisome, 
continuing the hollow channel that effectors pass through. 
1.4 Needle 
The T3S needle is an oligomer made up of repeating subunits of a small 
needle protein (PscF in P. aeruginosa) (Pastor et al., 2005). The T3S needle 
length is fixed within a species. In P. aeruginosa the needle is approximately 50 
nm, with an outer and inner diameter of 8 and 2 nm respectively (Pastor et al., 
2005). While P. aeruginosa needles have been isolated, their structure has not 
been well studied. Needles purified from Shigella showed that the needle protein 
oligomerizes into a helical structure with a 24 Å pitch with approximately 5.6 
subunits per turn (Cordes et al., 2003). The needle is capped by a proteinaceous 
tip complex. PcrV forms the P. aeruginosa T3S needle tip complex (Mueller et 
al., 2005). 
1.5 Translocators 
While the injectisome and needle are sufficient to secrete effector proteins 
out of the bacterium, effectors need to translocate across the plasma membrane 
of the target cell. In P. aeruginosa, two proteins (PopB and PopD) secreted by 
the T3S system are required for translocation of effectors into the host cell 
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(Dacheux et al., 2001; Sundin et al; 2004; Gouer et al., 2004). These 
translocators form pores in model membranes (Schoen et al., 2003; Faudry et 
al., 2006; Romano et al., 2011), and are found on host cell membranes after 
contact with P. aeruginosa (Goure et al., 2004), supporting the hypothesis that 
these translocators assemble into the translocon. 
PopB is the major translocator with a molecular weight of 40.3 kDa 
(Hauser et al., 1998). PopD is the minor translocator with a molecular weight of 
31.3 kDa. The structures of PopB and PopD are not well characterized because 
these proteins have been difficult to crystalize due to their hydrophobicity. A more 
in-depth characterization of these proteins is necessary to understand how they 
interact with membranes.   
It is hypothesized that the translocator proteins form the translocon 
spontaneously. This is an uncommon mechanism for membrane protein 
insertion, as most membrane proteins are inserted by complex cellular machinery 
involving the ribosome and chaperones (Cymer et al., 2014). The ability for these 
proteins to assemble on membranes spontaneously facilitates their study in 
model membranes. PopB and PopD translocator complexes can be reconstituted 
in liposomes (Romano et al., 2011).  
These P. aeruginosa translocator proteins are important for infection of the 
host cell, and very little is known about how they assemble on the host cell 
membrane.  Therefore it is important to study how PopB and PopD interact with 
the host cell to better understand how effectors are translocated in the T3S 
system. 
7 
1.6 Reconstituting translocators in membranes 
PopB and PopD assemble on model membranes, forming pores 
individually as well as in complex (Romano et al., 2011; Schoen et al., 2003; 
Faudry et al., 2006). When incubated together, PopB and PopD form a 
heterocomplex of eight PopB and eight PopD (Romano et al., 2011). This 
complex is of particular interest because when in the complex, the pore formation 
and membrane insertion of PopD is enhanced (Romano et al., 2011; Monopoli, 
2014).  Formation of this complex in model membranes is irreversible (Monopoli, 
2014).  
To maximize heterocomplex assembly, translocators must be added 
simultaneously to model membranes (Monopoli, 2014). Heterocomplex assembly 
in model membranes is optimized at mildly acidic pH (Romano et al., 2011), 
however the heterocomplex remains inserted in membranes upon neutralizing 
the pH (Monopoli, 2014). This allows for study of this complex at neutral pH, 
allowing for study of this complex in relation to other proteins.  
It is not known how the heterocomplex reconstituted in model membranes 
relates to the translocon inserted in host cells. Here the heterocomplex is studied 
to determine if it is functional for interaction with other components of the T3S 
system (specifically: P. aeruginosa and the T3S needle). Assessment of these 
interactions will provide insight into the relationship between the heterocomplex 
reconstituted in model membranes and the translocon formed in host cell 




INTERACTION OF MEMBRANE-RECONSTITUTED TRANSLOCATORS 
WITH ISOLATED P. AERUGINOSA T3S COMPONENTS 
2.1  Introduction 
We have shown that the P. aeruginosa translocators PopB and PopD 
assemble a heterocomplex in model membranes (Romano et al., 2011), however 
this heterocomplex has not been assessed in relation to its interaction with the 
rest of the T3S system. One way to evaluate this is to determine if other 
components of the P. aeruginosa T3S system, that are predicted to interact with 
the translocon, interact with the reconstituted complexes. One of these 
components is the tip complex. The tip complex is believed to be composed of 
the protein PcrV, and located at the tip of the needle formed by the protein PscF 
(Mueller et al., 2005; Pastor et al., 2005). To assess their ability to interact with 
the heterocomplex, we purified recombinant PcrV protein and initiated attempts 
to purify needles formed by P. aeruginosa.  
2.2  Experimental design 
Translocator heterocomplexes were reconstituted in model membranes by 
diluting a premixed solution of PopB and PopD in 6 M urea, into buffer containing 
liposomes (see Methods 2.5.1) (Romano et al., 2011). This was performed at 
mildly acidic pH (pH 4.3) to maximize binding and insertion of translocators 
(Faudry et al., 2006; Romano et al., 2011). The pH was neutralized before 
adding other T3S components. Previous studies indicate that the heterocomplex, 
when inserted at pH 4.3, remains stably inserted in membranes upon pH 
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neutralization (Monopoli, 2014) (Fig 2.1). After incubating with the T3S 
components, a flotation assay was performed to isolate the membranes (see 
Methods 2.5.2). Components that bound to the heterocomplexes would be 
present in the membrane fraction isolated from the flotation assay. As a control, 
the binding of the added components to the liposomal membranes would be 
evaluated by exactly the same procedure without adding the translocators. 
2.3  Results 
2.3.1 Purification of unmodified recombinant PcrV 
 The needle tip complex in the P. aeruginosa T3S system is believed to be 
made up of PcrV (Mueller et al., 2005). It is hypothesized that PcrV interacts 
directly with the translocon. Using the protocol outlined in 2.5.3, unmodified 
recombinant PcrV was purified to approximate 88% homogeneity (C. Sanchez, 
unpublished data) (Fig 2.2).  
2.3.2 Interaction of monomeric PcrV with heterocomplex 
The interaction of monomeric PcrV with the membrane-bound 
translocators was measured using the assay described in 2.2. To control for 
nonspecific binding of PcrV to membranes, PcrV was incubated with membranes 
in the absence of the heterocomplex at neutral pH. Membrane-bound protein was 
separated on an SDS-PAGE and the presence of PcrV was detected with a 
western blot (Fig 2.3). 
No binding of PcrV was seen after addition of monomeric PcrV (Fig 2.3). 
The absence of binding indicated that oligomeric PcrV or other T3S factors may 




Figure 2.1. PopB in heterocomplex remains bound to membranes after pH 
neutralization. Heterocomplexes of PopBV191CBodipy and PopD were reconstituted 
in membranes at pH 4 (lanes 1 and 2) and pH 7 (lane 3) (essentially as in 2.5.1). 
The pH was neutralized to pH 7 with 2μ 2M Trizma, pH 9.0 (lane 2), or was 
unchanged (lanes 1 and 3), before performing a flotation assay to isolate 
membrane bound protein (see Methods 2.5.2). Samples were TCA precipitated 
and separated on a 10% acrylamide SDS-PAGE. PopBV191CBodipy was detected 
by scanning with a Typhoon FLA 7000 gel scanner exciting at 488 nm. A sample 
containing the total amount of PopBV191CBodipy present was included as a 




Figure 2.2. Purification of unmodified recombinant monomeric PcrV. 
Unmodified recombinant monomeric PcrV was purified (see Methods 2.5.3). The 
purified PcrV was separated on a 10% acrylamide SDS-PAGE and stained with 
Coomassie (left) or transferred to a polyvinylidene fluoride (PVDF) membrane 
and detected with polyclonal anti-PcrV antibodies (right). PcrV appears as the 
dominant band in the gel stained with Coomassie (arrow). Molecular weights are 





Figure 2.3. Monomeric PcrV does not bind heterocomplex. The translocator 
heterocomplex was reconstituted in membranes (see Methods 2.5.1) and 
incubated with monomeric PcrV. Membrane bound protein was isolated with a 
flotation assay (see Methods 2.5.2), and TCA precipitated before separating on a 
10% acrylamide SDS-PAGE and transferring to a PVDF membrane. PcrV was 
detected with a polyclonal anti-PcrV antibody. Contents of the sample in each 
lane are indicated at the bottom. A sample containing the total amount of PcrV 





containing other factors secreted by P. aeruginosa did not affect monomeric PcrV 
binding (Fig 2.4). Purified oligomeric PcrV was not available, however we 
evaluated the possibility of using needles that contain the oligomers at the tip. 
T3S needles can be isolated from P. aeruginosa (Pastor et al., 2005; Gebus, 
2008) as described below. 
2.3.3 Purification of the T3S needle 
Previous studies indicate that T3S needles from P. aeruginosa and other 
bacteria can be sheared from the surface of the bacteria mechanically (Gebus, 
2008; Blaylock et al., 2010; Hoiczyk and Blobel, 2001). These needles can be 
further purified from other components using various methods. Two methods 
were adapted for purification of T3S needles from P. aeruginosa (see Methods 
2.5.4). The proteins isolated by the needle purification procedures were analyzed 
initially by SDS-PAGE and Coomassie staining. 
The needles are composed of the 9 kDa needle protein, PscF (Pastor et 
al., 2005). Therefore the presence of a dominant band at 9 kDa on an SDS-
PAGE would denote the presence of needles. To resolve this lower molecular 
weight protein, a Tricine SDS-PAGE was used instead of the traditional Laemmli 
SDS-PAGE (see Methods 2.5.4.4). This method involves an alternative buffering 
system that allows for complete separation of proteins smaller than 20 kDa 
(Schägger and von Jagow, 1987). The Tricine SDS-PAGE provided satisfactory 





Figure 2.4. Components secreted by P. aeruginosa do not enhance PcrV 
binding to the heterocomplex. The translocator heterocomplex was 
reconstituted in membranes (see Methods 2.5.1) and incubated with monomeric 
PcrV along with growth media (2 μg protein). Growth media was obtained after 
culturing P. aeruginosa cultured under T3S inducing conditions (see Methods 
2.5.4.1) until an OD600 of 0.8 was reached. Membrane bound protein was 
isolated with a flotation assay (see Methods 2.5.2), and TCA precipitated before 
separating on a 10% acrylamide SDS-PAGE and transferring to a PVDF 
membrane. PcrV was detected with polyclonal anti-PcrV antibodies. Contents of 
the sample in each lane are indicated at the bottom (growth media and 
membranes were present in both samples). A sample containing the total amount 




Figure 2.5. Tricine SDS-PAGE is superior to Laemmli SDS-PAGE in 
separating low molecular weight proteins. Partially purified P. aeruginosa T3S 
needles purified from PA103 using Method A (see Methods 2.5.4.1), were 
separated using (A) Tricine SDS-PAGE (see Methods 2.5.4.4) or (B) Laemmli 
SDS-PAGE and stained with Coomassie. Both gels contained 15% acrylamide. 
Molecular weights are indicated. The predicted molecular weight of the needle 






2.3.3.1 P. aeruginosa strain selection 
The needles were isolated from the surface of P. aeruginosa, but selection 
of an appropriate strain was necessary to facilitate needle purification. Since 
needle purification involves sheering of the needle, it is necessary to limit 
contaminants that can be obtained in the sheered in the process. One major 
component is the flagella. To avoid contamination with flagella, the aflagellated 
strains PA103 and the mutant CHAΔFliC were selected. PA103 is an aflagellated 
clinical isolate strain (Liu and Hsieh, 1973; Montie et al., 1982). CHA is a cystic 
fibrosis clinical isolate strain (Toussaint et al., 1993). The CHAΔFliC mutant does 
not express the flagellin protein FliC (Pastor et al., 2005). After sheering protein 
from the cell surface, a greater amount of 9 kDa protein was obtained from 
CHAΔFliC than from PA103 (Fig 2.5), suggesting a greater amount of PscF, and 
therefore needles, were obtained from this strain. Therefore the CHAΔFliC strain 
was selected for further needle purifications. Additionally, needles have been 
purified from this strain previously (Pastor et al., 2005). 
 There was a large amount of contaminating protein present after 
purification of the needles (Fig 2.6). It would be ideal to utilize a mutant strain that 
produces more T3S apparatuses on the surface, to increase the amount of 
needles. It is possible to increase T3S apparatus production by stimulating T3S, 
which can be induced in P. aeruginosa by cultivating in a low calcium 




Figure 2.6. A greater amount of 9 kDa protein was obtained from the 
surface of CHAΔFliC than PA103. CHAΔFliC and PA103 were cultivated as 
described in 2.5.4.1. Proteins were isolated from the surfaces of the bacteria by 
vortexing for 5 minutes at 4°C. Twenty microliters of undiluted protein were run 
on a 15% acrylamide Tricine SDS-PAGE and stained with Coomassie (see 
Methods 2.5.4.4). The P. aeruginosa strain from which the sample was isolated 
is indicated at the top. A strong 9 kDa band indicating the presence of PscF is 
seen in proteins isolated from CHAΔFliC (arrow), but not from PA103. Molecular 




2.3.3.2 Shearing needles and purification 
Previous studies indicate that T3S needles can be sheared by moderate 
agitation of the cells. These methods include resuspending the cells in buffer 
(Pastor et al., 2005; Baylock et al., 2010), passage through a needle (Espina et 
al., 2006), or vortexing (Journet et al., 2003). Other, more aggressive methods 
have been used including sonication and homogenization (Jessen et al., 2014; 
Hoiczyk and Blobel, 2001). Different needle shearing methods were examined 
(see Methods 2.5.4.3). The results from all methods except sonication are the 
same as those with gentle resuspension in buffer (Fig 2.7). Sonication increased 
the amount of protein (Fig 2.7, lane 5), but a similar protein distribution was 
observed by SDS-PAGE of proteins obtained by all shearing methods. A 9 kDa 
protein was obtained from all of the shearing methods. This suggests that simply 
washing the cells in buffer is sufficient to remove needles, and a more aggressive 
treatment is unnecessary and may only serve to increase contaminating protein.  
The large amount of contaminants in the needle purification could not be 
removed. Type III Secretion was stimulated to induce greater needle production, 
but this also increases protein secretion. A similar protein distribution was 
observed by SDS-PAGE of proteins isolated from the growth media, as from the 
needle purification (although the growth media was less concentrated) (Fig 2.7, 
lane 6). Therefore it is likely that a large amount of the contaminating protein was 
secreted protein. This indicates that the method of purification was not sufficient 
to remove the secreted components. Washing the bacteria to remove the 




Figure 2.7. Alternative needle shearing methods did not affect protein 
obtained. CHAΔFliC was cultivated as stated in 2.5.4.1. Needles were sheared 
from the surfaces of bacteria by resuspension (lane 1), homogenization (lane 2), 
passing through an 18G needle (lane 3), vortexing (lane 4), or sonication (lane 5) 
(see Methods 2.5.4.3). Growth media isolated from the same cultivated cells was 
also analyzed (lane 6). Samples were run on a 15% acrylamide Tricine SDS-




needles. The large amount of contaminants also hindered the ability to identify 
needles by transmission electron microscopy.  
 The final step of the purification protocol involves centrifugation of the 
protein, after which the pellets containing the needles were resuspended in 
buffer. A similar protein distribution was observed by SDS-PAGE of the 
supernatant as the purified needles (Fig 2.8, lanes 2 and 3), suggesting these 
isolates contained the same proteins. Additionally, the needle tip component, 
PcrV, was not enriched, and it was present in equal amounts in the supernatant 
and pellet (Fig 2.9). Therefore it is likely that this step did not effectively remove 
contaminating proteins or concentrate the needles. No pellets were observed 
after centrifugation even when the starting culture volume was increased eight 
fold, so it is likely that the resuspended pellet was merely residual supernatant 
that was diluted. It is likely that the amount of needles present at the beginning of 
the purification was very low, so no pellets were obtained. Protein purified using 
Method B (see Methods 2.5.4.2) did not enter the SDS-PAGE gel, and it is 
therefore unclear whether needles were successfully purified using this 
alternative method.  
2.4  Discussion and future research 
While the unmodified recombinant PcrV purification was successful, it was 
difficult to purify the T3S needles. While a band at 9 kDa was present when the 
sample was separated on an SDS-PAGE, it was unclear if this protein was the 
needle protein, PscF. Transmission electron microscopy could be performed with 
the purified fractions, but the large amount of contaminating proteins would likely  
21 
  
Figure 2.8. Needle precipitation by centrifugation. T3S needles were purified 
from CHAΔFliC using Method A (see Methods 2.5.4.1). Needles were sheared 
from the surfaces of bacteria by vortexing (see Methods 2.5.4.3). The needles 
were precipitated by centrifugation (20,000xg, 30 min, 4°C). The pellet containing 
the purified needles was resuspended and analyzed (lane 1). The supernatant 
after precipitation was also analyzed (lane 2). The supernatant contained a large 
amount of protein and was diluted 1:10 (lane 3). Samples were run on a 15% 
acrylamide Tricine SDS-PAGE and stained with Coomassie (see Methods 




Figure 2.9. PcrV is present in needle fraction but not enriched with 
purification. T3S needle purification fraction was prepared from CHAΔFliC using 
Method A (see Methods 2.5.4.1). Needles were sheared from the surfaces of 
bacteria by vortexing (see Methods 2.5.4.3). Aliquots from the purification steps 
were analyzed before filtering (lane 1) and after filtering (lane 2). The supernatant 
after precipitation of the needles was analyzed (lane 3) along with the purified 
needle fraction (lane 4). Samples were run on a 10% acrylamide SDS-PAGE and 
transferred to a PVDF membrane. PcrV was detected with polyclonal anti-PcrV 
antibodies. Molecular weights are indicated at left. Interestingly, PcrV dimers 





make it difficult to visualize any needles present. The purification method must be 
modified to decrease contaminants and concentrate PscF.  
The failure to purify T3S needles suggests that needles may not be 
present at the start of the purification. This could be determined if a western blot 
were performed with an anti-PscF antibody, which is not available. No significant 
amount of protein was lost through the steps of the purification, so it is unlikely 
that the needles were lost. It is also unlikely that the bacteria were not producing 
needles. It is more likely that a low amount of needles were produced, because 
the cells were not grown for a long enough time. It is also possible that the 
needles were not sheared successfully from the bacteria, but unlikely. Washing 
the cells is sufficient to remove needles from Yersinia (Journet et al., 2003), and 
was the method used to shear needles from P. aeruginosa previously (Pastor et 
al., 2005). In fact, free needles are found in the culture media of Shigella flexneri, 
suggesting that T3S needles are quite fragile (Cordes et al., 2003; Olive et al., 
2007). Gentler shearing methods, like washing the cells, yielded similar results to 
more aggressive methods like sonication and homogenization. This suggests 
that very little disruption is needed to remove proteins attached to the surface of 
P. aeruginosa. Furthermore, sonication and homogenization have potential to 
lyse the cells, increasing contaminants significantly.  
Monomeric PcrV alone, and in the presence of putative T3S needles did 
not bind the PopB:PopD heterocomplex reconstituted in model membranes. If 
this interaction does occur, it is likely that oligomeric PcrV is necessary, as the tip 
complex is an oligomer of PcrV (Mueller et al., 2005). The T3S needles contain 
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the tip complex and therefore could provide the oligomeric PcrV necessary to test 
this hypothesis. In fact, PcrV dimers were detected in purified needle samples. 
Purification of the T3S needles was difficult and therefore, unless the needles are 
purified, an alternative source of oligomeric PcrV is needed to test this 
hypothesis. One possibility is to measure the interaction directly with P. 
aeruginosa by determining if the cells can interact with the heterocomplex 
through the T3S needle. 
These results suggest that the heterocomplex formed in model 
membranes does not interact with the P. aeruginosa T3S system, but it is 
possible that these T3S components cannot bind the heterocomplex 
independently. The T3S system is a tightly regulated system, and the infection 
mechanism likely requires very precise interaction of the needle with the 
translocon, since no secreted protein is lost into the extracellular environment. 
Therefore it is likely that P. aeruginosa modulates the interaction with the 
translocon, and therefore must be present for the needle to engage with it. 
2.5  Methods 
2.5.1 Reconstituting the heterocomplex in model membranes 
 Binding reactions (75 μL) were prepared by equilibrating liposomes (65% 
POPC, 20% cholesterol, 15% POPS, Avanti Polar Lipids) to a final concentration 
of 5.94 mM in 50 mM sodium acetate, pH 4.3. The translocators were added to a 
final concentration of 900 nM PopB and 90 nM PopD from a premixed stock in 6 
M urea, 20 mM Tris pH 8.0, 20 mM glycine, 20 mM NaCl. After a 15 minute 
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incubation at 23°C, the pH of the binding reactions were neutralized with 2 μL of 
2 M Trizma, pH 9.0.  
2.5.2 Isolating membrane-bound components with a flotation assay 
Flotation assay was performed as in Romano et al., 2011. Purified PcrV 
was added to membrane bound heterocomplexes to a final concentration of 900 
nM (in 75 μL). The sample was incubated for 15 minutes at 23°C before mixing 
with 225 μL of a 67% sucrose solution. A 40% sucrose solution was layered on 
top (360 μL), followed by a 4% sucrose solution (240 μL). All sucrose solutions 
were prepared in 30 mM sodium acetate, 30 mM 2-(N-morpholino)ethanesulfonic 
acid (MES) pH 7.0. The sample was centrifuged for 50 minutes at 90,000xg, 4°C. 
The sucrose gradient was separated into 300 μL aliquots, removing from the 
bottom layer. A trichloroacetic acid (TCA) precipitation was performed with the 
top layer containing the membrane-bound fraction using 15 μg of bovine serum 
albumin as a carrier protein. A western blot was performed to detect for the 
presence of PcrV in the membrane-bound fraction using a polyclonal anti-PcrV 
antibody. 
2.5.3 Unmodified recombinant PcrV purification 
Twenty milliliters of an overnight culture of the E. coli expression strain 
BL21(DE3)star (Invitrogen) expressing a pAH50-PcrV plasmid in Luria-Bertani 
(LB) broth was diluted in 1 L LB containing 100 μg/mL ampicillin. The culture was 
incubated at 37°C with shaking (150 rpm) until the optical density at 600 nm 
(OD600) reached 0.60 (~3.5 hours), at which point Isopropyl α-D-
thiogalactopyranoside (IPTG, Gold Biochemicals) was added to a final 
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concentration of 1 mM to induce PcrV expression. After an additional four hours 
of incubation, the cultures were harvested by centrifugation (4,400xg, 15 min, 
4°C). The cell pellets were resuspended in 50 mM Tris-HCl, pH 8.8, and protease 
inhibitors were added (40 μg/mL PMSF and 170 μg/mL Benzamididine). The 
cells were lysed by passing through a Microfluidics M-110L microfluidizer two 
times at 18,000 psi. The cell lysate was centrifuged (20,000xg, 15 min, 4°C) 
retaining the supernatant.  
An ammonium sulfate precipitation with 30-70% gradient was performed 
with the cleared cell lysate as follows. Ammonium sulfate was added with 
constant stirring to a final concentration of 30% w/v at 4°C. After stirring for 30 
min, the solution was centrifuged (10,000xg, 10 min, 4°C), and the supernatant 
was retained. The precipitation was repeated with 70% ammonium sulfate, and 
the pellet was retained after centrifugation. The pellet was resuspended and 
dialyzed against 50 mM Tris-HCl, 100 mM NaCl, pH 8.0.  
The sample was loaded onto a Q-Sepharose AEC column (GE 
Healthcare) equilibrated with 50 mM Tris-HCl, pH 8.0. A 50 mL gradient of 50-
500 mM NaCl in 50 mM Tris-HCl, pH 8.0 was applied to elute PcrV. PcrV eluted 
in 150-300 mM NaCl. Peak fractions (detected by absorbance at 280 nm) were 
separated on an SDS-PAGE to confirm that PcrV was present, before pooling 
and dialyzing overnight against 50 mM Hepes, 150 mM NaCl, pH 7.5. The 
sample was concentrated with a Vivaspin 20 concentrator with a 10 kDa cutoff 
(GE Healthcare), and applied to a Superdex-200 GL 10/30 column (GE 
Healthcare). PcrV eluted in 11-14 mL. Peak fractions (detected by absorbance at 
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280 nm) were separated on an SDS-PAGE to confirm that PcrV was present, 
before pooling and dialyzing overnight against 20 mM MES, pH 6.5. The dialyzed 
sample was loaded onto a Hi-Trap Q-HP column (GE Healthcare) equilibrated in 
20 mM MES, pH 6.5. A 50 mL gradient of 0-500 mM NaCl in 20 mM MES, pH 6.5 
was applied to elute PcrV. PcrV eluted in 475-500 mM NaCl. Peak fractions 
(detected by absorbance at 280 nm) were separated on an SDS-PAGE to 
confirm that PcrV was present, before pooling and adding glycerol (to 10% v/v). 
The purified protein was aliquoted and flash frozen in liquid nitrogen before 
storage at -80°C.  
2.5.4 Needle purification 
2.5.4.1 Method A 
Method A was adapted from Gebus, 2008. An overnight culture of P. 
aeruginosa (CHAΔFliC or PA103) in LB was diluted to an OD of 0.1 in 1 L LB. A 
low calcium environment was created to induce T3S by chelating calcium with 
EDTA (5 mM final concentration).  The CHAΔFliC strain was graciously provided 
by Ina Attrée (Université Grenoble Alpes). After chelating the calcium, the media 
was supplemented with MgCl2 (20 mM final concentration). Cells were cultivated 
at 37°C with shaking (150 rpm) until the cells reached an OD600 of 0.8 (~3 hours). 
The cells were pelleted (8,000xg, 10 min, 4°C). Cells were resuspended at 4°C in 
10 mL 50 mM Tris-HCl, pH 7.5 and needles were sheared. Cells were removed 
by centrifuging (8,000xg, 10 min, 4°C) followed by passing the supernatant 
through a 0.45 μm acetate membrane (Whatman). Needles were precipitated by 
centrifugation (20,000xg, 30 min, 4°C). The pellet was resuspended in 1 mL 50 
28 
mM Tris-HCl, pH 7.5. Needles were aliquoted and flash frozen in liquid nitrogen 
before storing at -80°C.  
2.5.4.2 Method B 
Method B was adapted from Pastor et al., 2005. P. aeruginosa (CHAΔFliC 
or PA103) cells were cultivated as in 2.5.4.1. The cells were pelleted (5,700xg, 
10 min, 4°C). Cells were resuspended with 30 mL 20 mM Tris-HCl, pH 7.5 and 
needles were sheared. Cells were removed by centrifuging (5,700xg, 10 min, 
4°C) followed by passing the supernatant through a filter as in 2.5.4.1. Needles 
were pelleted by centrifugation (18,000xg, 30 min, 4°C). The pellet was 
resuspended in 15 mL Tris-HCl 20 mM, pH 7.5 with 0.1% (w/v) 3-((3-
cholamidopropyl) dimethylammonio)-1-propanesulfonate (CHAPS). Insoluble 
protein was removed by centrifugation (50,000xg, 30 min, 4°C). The needles 
were precipitated on ice for 1 hour with 10% (w/v) polyethylene glycol (PEG) 
6000 and 100 mM NaCl. Needles were collected by centrifugation (50,000xg, 30 
min, 4°C). The pellet was resuspended in 1 mL 20 mM Tris-HCl, pH 7.5. Needles 
were aliquoted and flash frozen in liquid nitrogen before storing at -80°C. 
2.5.4.3 Needle shearing methods 
Several needle-shearing methods were attempted: 
 Washing: Cells were resuspended gently in buffer (50 mM Tris-HCl, pH 
7.5) by incubating on ice with shaking (100 rpm) until the pellets were 
completely resuspended (Pastor et al., 2005; Journet et al., 2003). 
 Vortexing: Cells were resuspended in buffer  (50 mM Tris-HCl, pH 7.5) 
and vortexed for 5 minutes at 4°C (in a cold room). Cells were vortexed for 
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five 1 minute intervals with a 1 minute incubation on ice between (Gebus, 
2008; Blaylock et al., 2010). 
 Sonication: Cells were resuspended in buffer (50 mM Tris-HCl, pH 7.5) 
and the cell suspension was sonicated at maximum amplitude for one 
second on ice. This was repeated five times. 
 Homogenization: Cells were resuspended in buffer (50 mM Tris-HCl, pH 
7.5) and the cell suspension was transferred to a glass homogenizer and 
the sample was homogenized for fifty cycles (Jessen et al., 2014; Cordes 
et al., 2003). 
 Passing through a needle: After resuspending cells in buffer, cells were 
passed through a 25G needle five times (Zhang et al., 2007; Espina et al., 
2006; Mueller et al., 2005). 
2.5.4.4 Tricine SDS-PAGE 
The Tricine SDS-PAGE protocol was adapted from Schägger and von 
Jagow, 1987. The gel recipe is included in Table 2.1. A 15% acrylamide 
separating gel was poured and allowed to polymerized for 30 minutes before 
pouring a 4% stacking gel. Samples were prepared with sample buffer (180 mM 
Trizma, 15% v/v glycerol, 7.5 mM EDTA, 0.02% w/v bromophenol blue, 3.65% 
w/v SDS), heated to 95°C for 5 minutes, and loaded onto the gel. The gel was 
run in a Mini-Protean gel running apparatus (Bio-Rad). The cathode buffer 
contained 100 mM Tris, 100 mM Tricine, 0.1% SDS, pH 8.25. The anode buffer 
contained 100 mM Tris, 22.5 mM HCl, pH 8.9. Gels were run at 60 V until the dye 
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front entered the stacking gel after which the voltage was increased to 100 V until 







Table 2.1. Gel recipe for Tricine SDS-PAGE. Adapted from Schägger and von 
Jagow, 1987. The components of the stacking and separating gel are indicated 






 4% Stacking 15% Separating 
    Acrylamide (30%) 0.83 5 
    0.5 M Tris 8.8 — 1.875 
    0.5 M Tris 6.8 1.26 — 
    Add water to final volume 2.77 2.925 
    SDS (10%) 0.05 0.1 
Polymerize by adding:   
    APS (10%) 0.05 0.1 
 TEMED 0.004 0.004 
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CHAPTER 3 
INTERACTION OF P. AERUGINOSA WITH TRANSLOCATORS 
RECONSTITUTED IN MODEL MEMBRANES 
3.1 Introduction 
Monomeric PcrV did not interact with the translocator heterocomplex 
reconstituted in model membranes (see 2.3.2). It is likely that PcrV must be in an 
oligomeric state to interact with the heterocomplex, however oligomeric PcrV was 
difficult to isolate (C. Sanchez, unpublished data), and T3S needles (containing 
the PcrV tip complex) were also difficult to isolate. As an alternative method to 
study this interaction, live P. aeruginosa cells were utilized. By incubating P. 
aeruginosa with the translocator heterocomplexes reconstituted in model 
membranes, the functionality for interaction of the heterocomplex with other 
components of the T3S system was studied. 
3.1.1 Experimental design  
To measure P. aeruginosa interaction with the membrane-reconstituted 
heterocomplex, binding of the bacteria to liposomes was measured. The P. 
aeruginosa strain PA103ΩPopD was selected for this assay, because it does not 
produce the translocators PopB and PopD. This prevented any interactions 
between the bacteria and liposomes through translocators produced by the 
bacteria. To track liposomes, a fluorescent lipid was added. 
3.1.1.1 Liposome composition 
It has been shown that liposomes could interact with bacteria (Drulis-
Kawa, and Dorotkiewicz-Jach, 2010). Therefore it was important to select a 
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liposome composition that minimized interactions between the liposomes and P. 
aeruginosa for binding through the translocator complexes to be accurately 
measured. Bucki et al. showed that inclusion of a charged fluorescent label 
increases interaction with P. aeruginosa (2004). Additionally, previous studies 
indicate P. aeruginosa binds to liposomes containing Rhodamine-1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DHPE) (F. Romano, 
unpublished results). This phospholipid contains a charged Rhodamine moiety 
on the head group such that it is accessible to the bacteria. NBD-cholesterol was 
selected for these experiments because the NBD label is buried in the lipid 
bilayer, and no charged residues are exposed on the membrane surface. This 
fluorophore selection will minimize any dye-bacteria interaction. The lipid 
composition POPC:cholesterol:POPS:NBD-cholesterol at molar ratio 
65:19.8:15:0.2 was selected as it maximizes assembly of the translocator 
complexes in model membranes (Romano et al., 2011). 
3.1.1.2 Heterocomplexes cannot be formed in the absence of homo-
oligomers 
The translocators were reconstituted in membranes before incubating with 
bacteria. The PopB:PopD heterocomplex is formed by incubating one 
translocator (PopB) in a ten times excess of the other (PopD); this ensures all of 
the PopD present is in a heterocomplex, so the amount of heterocomplex present 
in a sample is known (Romano et al., submitted). Since the heterocomplex is a 
complex of eight PopB and eight PopD, only 18% of the total protein present was 
in a heterocomplex, and the remaining 82% consisted of PopB homo-oligomers 
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(Fig 3.1, A). Therefore binding to the PopB homo-oligomers contributed to the 
signal obtained when measuring binding to the heterocomplex, so binding to 
PopB homo-oligomers (in the absence of PopD) was also measured. Binding to 
PopD homo-oligomers was measured as well for a comparison. 
3.1.1.3 Assay to measure P. aeruginosa-liposome interactions 
The binding of P. aeruginosa to liposomes was measured as follows. The 
translocators were reconstituted in liposomes (Fig 3.2, A), and the liposomes 
were then incubated with bacteria (Fig 3.2, B). Cells were pelleted along with any 
bound liposomes (Fig 3.2, C). The pellets were resuspended and liposome 
binding was measured by measuring the fluorescence emission intensity of the 
liposomes (Fig 3.2, D). Higher fluorescence emission intensity indicated greater 
liposome binding. These measurements were also performed with liposomes 
without membrane-bound translocators to measure nonspecific binding of the 
bacteria to liposomes. 
3.2 Results and discussion 
3.2.1 Binding of P. aeruginosa to liposomes is enhanced when the 
heterocomplex is present 
The interaction between PA103ΩPopD and liposomes containing 
reconstituted translocator complexes was measured using the assay described in 
3.1.1.3. Binding to the heterocomplex as well as both PopB and PopD homo-
oligomers was measured. Binding was greatest when the heterocomplex was 
present (Fig 3.3, red). The relative fluorescence emission for the heterocomplex 
sample was 36% greater than that of the PopB homo-oligomer sample. Since  
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Figure 3.1. Heterocomplexes cannot be formed in the absence of homo-
oligomers. PopB and PopD form homo-oligomers as well as heterocomplexes in 
model membranes (Romano et al., submitted). Therefore, to reconstitute the 
PopB:PopD heterocomplex in liposomes, PopB was added in a ten times excess 
of PopD. (A) When forming the heterocomplex, all of the PopD (blue) was 
incorporated into heterocomplexes while PopB (green) also formed homo-
oligomers on the liposomes (yellow). Therefore there were more PopB homo-
oligomers than heterocomplexes present, and the number of PopB homo-
oligomers present was about the same as the number present in (B) the sample 




Figure 3.2. Measuring the interaction between P. aeruginosa and the 
heterocomplex. (A) Translocator complexes of PopB (green) and PopD (blue) 
were reconstituted in liposomes (yellow) labeled with NBD-cholesterol (red dots). 
(B) P. aeruginosa (purple) was incubated with liposomes to allow for interaction 
with the T3S needle (black). (C) Cells were pelleted along with bound liposomes. 
(D) The pellet was resuspended and fluorescence emission of NBD-cholesterol 
was measured to measure the amount of liposome binding. Binding to liposomes 




Figure 3.3. P. aeruginosa binds to Liposomes with membrane-bound 
translocators. P. aeruginosa interactions with fluorescently-labeled liposomes 
containing translocator heterocomplexes (red) or homo-oligomers of PopB (blue) 
or PopD (red) were measured with fluorescence spectroscopy (Methods section 
3.4.1). Translocator complexes (homo-oligomers and heterocomplexes) were 
reconstituted on liposomes (amounts in each sample indicated at bottom). 
Protein:lipid ratio was 1:6000, with lipid composition 
POPC:cholesterol:POPS:NBD-cholesterol at molar ratio 65:19.8:15:0.2.  
PA103ΩPopD was grown to OD600 of 1.2 under conditions that induced T3S (see 
Methods 3.5.4.1). Cells were washed and diluted in PBS to OD600 of 0.25 before 
incubating with the liposomes. Fluorescence emission intensity was normalized 
to the maximum fluorescence value. Binding to liposomes lacking translocators 




only 18% of the heterocomplex sample consists of heterocomplexes, this large 
increase in fluorescence was due to a small amount of protein.  
Binding to PopB and PopD homo-oligomers appears to be dependent on 
the amount of protein present. The amount of PopB was ten times greater than 
PopD in their respective homo-oligomer samples, and the relative fluorescence 
emission of the sample containing PopD homo-oligomers was 8% of that of the 
PopB homo-oligomer sample (Fig 3.3, blue and green). This dependence on 
protein amount was not true for the sample containing heterocomplexes, which 
only contained 10% more protein than the PopB homo-oligomer sample. These 
results indicate that binding to of P. aeruginosa to liposomes is enhanced in the 
presence of the heterocomplex compared to the homo-oligomers. 
3.2.2 BSA blocked P. aeruginosa interactions with PopB and PopD 
independently of their oligomeric arrangement 
It was possible that the interactions seen between bacteria and liposomes 
were due to nonspecific protein-protein interactions. Bovine serum albumin 
(BSA) can be added to cells to block nonspecific protein-protein interactions 
(Deng et al., 2007). BSA was added to P. aeruginosa to a final concentration of 
1% before incubating with liposomes. BSA did not affect binding to liposomes 
without translocators (data not shown). When BSA was present, the relative 
fluorescence emission of the sample containing heterocomplexes decreased to 
0.20 ± 0.03 RFUs (Fig 3.4, purple). The relative fluorescence emission of the 
PopB homo-oligomer sample decreased similarly, to 0.25 ± 0.034RFUs (Fig 3.4, 
orange). In both cases, binding was not blocked entirely.  
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Figure 3.4. Adding BSA to P. aeruginosa blocked binding to translocators. 
P. aeruginosa interactions with liposomes with membrane-bound translocator 
complexes after blocking cells with 1% BSA (+BSA) or not, were measured using 
fluorescently labeled liposomes (see Methods 3.4.1). Heterocomplexes (purple) 
and PopB homo-oligomers (orange) were reconstituted on liposomes 
(heterocomplex: 4.3 pmol PopB and 0.43 pmol PopD), (homo-oligomer: 4.3 pmol 
PopB). Protein:lipid ratio was 1:6000, with lipid composition 
POPC:cholesterol:POPS:NBD-cholesterol at molar ratio 65:19.8:15:0.2. 
PA103ΩPopD was grown to OD600 of 1.2 under conditions that induced T3S, 
cells were washed and diluted in PBS with or without 1% BSA to OD600 of 0.25 
before incubating with proteoliposomes. Fluorescence emission intensity was 
normalized to the maximum fluorescence value. Nonspecific binding to 
liposomes lacking translocators was subtracted. Error bars indicate the range 




These results do not show any specificity for P. aeruginosa binding to the 
heterocomplex compared to the PopB homo-oligomer, as the binding 
enhancement seen in the presence of the heterocomplex was lost upon addition 
of BSA. One percent BSA blocks a large amount of protein-protein interactions 
between P. aeruginosa and the translocators in either oligomeric state, 
suggesting that at least some of interactions between are nonspecific. 
It is possible that BSA blocked specific interactions with complexes 
reconstituted in liposomes. BSA is commonly used to block nonspecific 
interactions when host cells are present (Raybourne and Bunning, 1994). In the 
presence of a host cell, bacterial adhesins can recognize the host and aid in the 
bacterial-host interaction. In this study, model membranes were selected in place 
of eukaryotic cells. Therefore factors that normally would aid in the cellular 
interactions are not present, and therefore BSA could have a more significant 
effect on binding, such as interfering with specific protein-protein interactions. 
3.2.3 P. aeruginosa bound translocator complexes without the T3S 
apparatus 
It is possible to determine if binding to the membrane-reconstituted 
heterocomplex is dependent on the T3S system, by measuring the interactions 
with a mutant that does not produce the T3S apparatus. The PAKΔPscC mutant 
was selected for these experiments because it lacks the secretin component of 
the T3S apparatus and therefore does not produce the apparatus or secrete any 
effectors (Lee et al., 2005). Wild-type PAK was selected as a control. 
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Binding of P. aeruginosa to liposomes with and without the heterocomplex 
was compared. In the previous experiments (3.2.1 and 3.2.2) nonspecific binding 
to liposomes was subtracted from the measurements. Here the binding of the 
T3S apparatus was in question, not the translocator complexes present, and 
therefore liposome binding was included in the comparison. The relative 
fluorescence of the sample containing PAK plus liposomes with or without 
translocators was similar (Fig 3.5, blue), suggesting PAK bound liposomes with 
and without translocators equally. The relative fluorescence of the sample 
containing PAKΔPscC plus liposomes was lower when the heterocomplexes 
were absent (Fig 3.5, red). This suggests that binding of the PAKΔPscC mutant 
increased when heterocomplexes were present (Fig 3.5, red). These results 
suggest that P. aeruginosa does not bind to the heterocomplex through the T3S 
apparatus.   
The heterocomplex sample contained PopB homo-oligomers, since PopB 
was added in excess to force all of the PopD into heterocomplexes (Fig 3.1, A). 
In some bacterial species, T3S translocators, when in a different oligomeric state, 
perform alternative functions in addition to translocation. For example, in the 
Shigella T3S system, IpaC functions to translocate effectors when in complex 
with IpaB, however in its homo-oligomeric state it performs a different role 
(Osiecki et al., 2001; Mounier et al., 2009). It is therefore possible that PopB 
homo-oligomers and PopB:PopD heterocomplexes both play a role 
physiologically. If the PopB homo-oligomers interact with the bacteria through a 




Figure 3.5. P. aeruginosa binds to the heterocomplex in the absence of the 
T3S apparatus. P. aeruginosa interactions with fluorescently-labeled liposomes 
with and without translocators bound were measured when the T3S apparatus 
was present (blue) or absent (red) (see Methods 3.4.1). Translocator 
heterocomplexes were reconstituted on liposomes (4.3 pmol PopB and 0.43 
pmol PopD). Composition of each sample is indicated at bottom.  Protein:lipid 
ratio was 1:6000, with lipid composition POPC:cholesterol:POPS:NBD-
cholesterol at molar ratio 65:19.8:15:0.2. PAK or PAKΔPscC (no T3S apparatus) 
was grown to OD600 of 1.2 under conditions that induced T3S; cells were washed 
and diluted in PBS to OD600 of 0.25 before incubating with liposomes. 
Fluorescence emission intensity was normalized to the maximum fluorescence 
value. Error bars indicate the range between two independent measurements. 
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ΔPscC mutant. Binding to PopB homo-oligomers alone was not measured, 
however, so it is not clear how much this contributed to the signal. Therefore it is 
not clear if one translocator oligomer was active to interacting with the bacteria 
when the T3S apparatus was absent.   
Wild-type PAK produced the translocators PopB and PopD, and secreted 
them into the media (data not shown), however is unclear whether these 
translocators are inserted into liposomes. The hydrophobic translocators 
aggregate in solution (Tardy et al., 1999; Hume et al., 2003), so even if PAK did 
not insert these translocators, secreted translocator aggregates likely stuck to the 
liposomes. The liposomes may have become saturated with translocators. 
Binding to these translocators (even if nonspecific) may have made the 
reconstituted translocator complexes inaccessible, explaining why the 
fluorescence signal did not increase when the heterocomplex was present (Fig 
3.5, blue). These results exemplify the importance of using a mutant strain that 
does not produce the translocators to measure interactions with the translocator 
complexes in liposomes.  
3.3 Conclusion 
The use of fluorescently labeled liposomes to assay P. aeruginosa binding 
allowed for bacteria-liposome interactions to be measured efficiently. Measuring 
interactions between the bacteria and the membrane-reconstituted translocators 
was possible, however it was difficult to determine if these interactions occurred 
through the T3S apparatus. There was a broad distribution of the binding data 
obtained. The assay used is an innovative method developed to allow for a more 
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high-throughput measurement of liposome-bacteria interactions than 
fluorescence microscopy. While Luisi et al. used a similar method to measure 
liposome binding, the application of this method to identify bacterial-protein 
complex interactions is novel and likely needs to be modified to increase 
precision and reproducibility of measurements (Luisi et al., 1998). 
Despite possible limitations in the assay, it is clear that P. aeruginosa 
more readily binds the reconstituted heterocomplex than homo-oligomers of 
either translocator. The interactions may be weak, but entropically favored when 
the translocon is inserted in close proximity of the needle in vivo when the 
bacteria are attached to the host cell. Further research is necessary to determine 
if the heterocomplex reconstituted in model membranes is functional for this type 
of interaction. 
3.4  Methods 
3.4.1 Measuring P. aeruginosa binding to translocator complexes in 
liposomes 
Homo-oligomers and heterocomplexes were reconstituted in liposomes 
(37.5 μM) (65% POPC, 19.8% cholesterol, 15% POPS, 0.2% NBD-Cholesterol, 
Avanti Polar Lipids) as described in 2.5.1, with the final concentration of PopB 
and PopD being 56.8 nM and 5.68 nM respectively. The pH was neutralized with 
2 μL of 2 M Trizma pH 9.00. Homo-oligomers were formed with either 56.8 nM 
PopB or 5.68 nM PopD in 37.5 μM liposomes. PA103ΩPopD was cultivated as in 
2.5.4.1 to induce T3S. Cells were grown until they reached an OD600 of 1.2. Cells 
were washed in PBS, pH 7.2 and collected by centrifugation (600xg, 10 min, 
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4°C). The cell pellet was resuspended in 10 mM phosphate, 137 mM NaCl, 2.7 
mM KCl, pH 7.2 (PBS) and diluted to OD600 of 0.25. Four hundred and fifty 
microliters of cells were transferred to a glass culture tube. Liposome-bacteria 
interactions were measured using a protocol adapted from Luisi et al., 1998. To 
the glass culture tube, 75 μL of proteoliposomes were added. Cells and 
liposomes were incubated for 15 min with shaking (150 rpm), 23°C. Cells and 
bound liposomes were pelleted (1,200xg, 10 min, 23°C). Pellets were 
resuspended in 300 μL PBS, pH 7.2 and the fluorescence reading was taken by 
exciting the sample at 485 nm (bandpass 5) and measuring emitted light at 550 




CHAPTER 4  
CHARACTERIZATION OF THE P. AERUGINOSA T3SS TRANSLOCON  
ISOLATED FROM INFECTED RBCS 
4.1 Introduction 
  The heterocomplex reconstituted in model membranes is a hexadecamer 
of eight PopB and eight PopD (Romano et al., submitted).  Since the molecular 
weights of PopB and PopD are 40.3 kDa and 31.3 kDa respectively, the P. 
aeruginosa heterocomplex is predicted to have a molecular weight of 601 kDa 
(Romano et al., submitted). The molecular weight of the native P. aeruginosa 
translocon has not been determined. The Y. enterocolitica T3S translocon 
formed by contact with red blood cells (RBCs) has been isolated, and the 
molecular weight of the complex was estimated to be between 500 and 700 kDa 
using Blue Native (BN)-PAGE (Montagner et al., 2011). A BN-PAGE can be used 
to roughly estimate the molecular weight of the P. aeruginosa translocon, which 
will give insight into how it relates to the heterocomplex formed in model 
membranes. 
  The heterocomplex reconstituted in model membranes has a 1:1 
stoichiometry of PopB to PopD (Romano et al., submitted). This diverges from 
the 5:1 translocator stoichiometry of the Shigella translocon (Dickenson et al., 
2013). The stoichiometry of the native P. aeruginosa translocon is not known. 
The translocon, isolated by BN-PAGE, can be further analyzed in a second 
dimension by a denaturing SDS-PAGE (Fiala et al., 2011). This will separate the 
translocators present in the translocon, allowing for their relative amounts to be 
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compared. If the translocon forms a 1:1 complex, an equal amount of PopB and 
PopD will be detected. This will provide greater insight into the structure of the P. 
aeruginosa translocon and will determine how the translocon formed in cell 
membranes relates to the heterocomplex formed in model membranes. 
4.2 Experimental Design 
4.2.1 Inducing P. aeruginosa contact with RBCs 
The translocon was to be isolated from mammalian cells. To perform the 
analysis by BN-PAGE, a large amount of translocon complexes need to be 
isolated (about 60 μg total protein per lane) (Montagner et al., 2011). This would 
require a large amount of cultured cells. A good alternative is to use mammalian 
RBCs. RBCs can be obtained in high amounts and lysis can easily be assessed. 
T3S translocons have been isolated from RBC membranes after contact with Y. 
enterocolitica (Montagner et al., 2011).   
P. aeruginosa was incubated with RBCs at a multiplicity of infection (MOI) 
of 3 (Fig 4.1, 1). Bacteria-RBC contact was inducted by centrifugation (Fig 4.1, 2, 
B). The pelleted cells were incubated at 37°C to allow for the translocon 
formation to proceed (Fig 4.1, 2, C). The cells were then resuspended (Fig 4.1, 2, 
A). This process was repeated four times to increase cell contact, which 
increased the number of translocons formed (Broz et al., 2007). 
4.2.2 Isolating RBC membranes 
After contact with P. aeruginosa, RBCs lyse (Goure, 2005) (Fig 4.1, 3). 
The lysed RBCs were separated from bacteria by centrifugation (Fig 4.1, 4). RBC 
membranes containing the translocon complexes were isolated from unbound  
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Figure 4.1. Schematic of method used to induce P. aeruginosa contact with 
RBCs. (1) P. aeruginosa (purple) was mixed with RBCs (red) at an MOI of 3 in a 
3 to one ratio of 30 mM Tris-HCl, 150 mM NaCl, pH 7.4.  (2) Translocons were 
formed on RBCs by bacteria-RBC contact, which was facilitated by (B) pelleting 
the cells (1,000xg, 10 min, 37°C). (C) Pellets were incubated for 10 minutes at 
37°C and (A) resuspended by shaking (100 rpm, 2 min, 37°C). This procedure 
was repeated three more times to maximize the number of translocons inserted. 
(3) T3S protein injection induced RBC lysis. (4) Bacteria were removed by 
centrifugation (1,500xg, 10 min, 4°C). (5) Lysed RBCs were mixed with sucrose 
and a sucrose gradient was established. (6) RBC membranes were floated by 




proteins and other cellular components by floating on a sucrose gradient (Fig 4.1, 
5 and 6). The RBC membranes were pelleted and stored at -20°C (Fig 4.1, 7).  
The proteins present on the RBC membranes were separated on an SDS-
PAGE and transferred to a polyvinylidene fluoride (PVDF) membrane. PopB and 
PopD were detected with polyclonal antibodies. The presence of the 
translocators would suggest that the translocon was present on the RBC 
membrane. 
4.2.3 Isolating the translocon from RBC membranes 
The translocon was isolated from RBC membranes. The RBC membranes 
needed to be solubilized with mild detergents to maintain the quaternary 
structure of the translocon. Selecting detergents to dissolve the membrane 
without disrupting the protein-protein interactions within the translocon complex 
was not trivial. The ideal detergent for isolating membrane protein complexes 
varies depending on the complex size and stability, as well as the charges and 
hydrophobicity of the proteins in the complex (Linke, 2009). Since a BN-PAGE 
was to be performed, a nonionic detergent needed to be selected (see 4.2.4). 
Three nonionic detergents were selected for these experiments: Triton X-100, 
digitonin, and n-Dodecyl β-D-maltoside (DDM). 
The detergent concentration also has a significant impact on the 
solubilization of a membrane protein complex. When detergents are added to 
membranes, they are first incorporated into the membrane bilayer. As more 
detergent is added, the membrane becomes saturated. The critical micellization 
concentration (CMC) of a detergent is the concentration at which micelles begin 
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to form (Linke, 2009). Once the membrane is saturated, if enough additional 
detergent is added for the concentration of free detergent to rise above the CMC, 
the membrane begins to solubilize (Lichtenberg, 2013). Therefore to fully 
solubilize the membrane, the detergent concentration must not only be high 
enough to saturate the membrane, but also high enough that the free detergent 
concentration is above the CMC. The CMC is a property of a detergent that does 
not change if the temperature remains constant (Linke, 2009). The amount of 
detergent needed to saturate the membrane depends not only on the amount of 
membrane present, but also on the membrane composition (Linke, 2009). 
Therefore several different detergent concentrations were tested in their ability to 
solubilize the RBC membranes to isolate the translocon.  
4.2.4 Estimating the molecular weight of the translocon using BN-PAGE 
After solubilization, a BN-PAGE could be performed to estimate the 
molecular weight of the translocon. The BN-PAGE is a method that separates 
membrane proteins using PAGE in non-denaturing (native) conditions. This 
method is similar to SDS-PAGE in that a reagent is added to negatively charge 
the proteins, a factor that distinguishes BN-PAGE from Native-PAGE. Coomassie 
brilliant blue G250 binds to the hydrophobic regions of solubilized membrane 
proteins, giving them a negative charge without denaturing the proteins 
(Schägger et al., 1994). This causes all proteins to migrate in the same direction 
in an electric field. For this reason, nonionic detergents must be used to 
solubilize membrane protein complexes. Unlike SDS-PAGE, BN-PAGE cannot 
be used to accurately calculate the molecular weight of a protein complex, but it 
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can be useful to estimate oligomerization states. 
The solubilized translocon isolated from RBC membranes was separated 
by BN-PAGE. A gradient acrylamide gel was used to allow for the separation of 
complexes with a broad range of molecular weights. A western blot was 
performed to detect for the presence of the translocator proteins. 
4.3 Results and Discussion 
4.3.1 Translocators were found on RBC membranes after contact with P. 
aeruginosa 
The proteins present on the RBC membranes were separated on a 10% 
acrylamide SDS-PAGE and transferred to a PVDF membrane. PopB and PopD 
were detected with polyclonal antibodies. Lysed P. aeruginosa as well as RBC 
membranes that did not come in contact with P. aeruginosa were included in the 
gel as a control (Fig 4.2, A and B, lanes 2 and 3). RBCs membranes that did not 
come in contact with P. aeruginosa were prepared by lysing RBCs with a 
hypotonic solution. These RBC membranes were isolated from other cellular 
components using a flotation assay (Fig 4.1, 5 and 6).    
PopD was detected in the RBC membranes following contact with P. 
aeruginosa. A band at the predicted molecular weight of PopD (31.3 kDa) was 
detected (Fig 4.2, A, lane 1, arrow), however the anti-PopD antibodies detected 
several other proteins in this sample. The ~37 kDa and ~80 kDa bands were also 
present in the lysed bacteria (Fig 4.2, A, lane 2), suggesting this was nonspecific 
binding of the antibody to a bacterial protein that was also found on RBC 
membranes after contact with P. aeruginosa. The other bands were not detected 
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Figure 4.2. Translocators were found on RBC membranes after contact with 
P. aeruginosa. Translocators (A) PopD and (B) PopB were detected after 
separation on a 10% acrylamide SDS-PAGE and transferring to a PVDF 
membrane. (1) RBC membranes isolated by flotation assay after contact with P. 
aeruginosa. (2) P. aeruginosa cell lysate after sonication. (3) RBC membranes 
that did not come in contact with P. aeruginosa. Arrow indicates the predicted 
migration of PopD in A, and PopB in B. Translocators were detected with 




in the RBC membranes that did not come in contact with P. aeruginosa (Fig 4.2, 
A, lane 3), so they are not mammalian proteins. These other bands could be 
secreted bacterial proteins that were not obtained when the bacteria were lysed. 
A single band was detected at 40 kDa by the anti-PopB antibodies in the 
RBC membranes following contact with P. aeruginosa (Fig 4.2, B, lane 1, arrow). 
The anti-PopB antibodies detected several other proteins in the lysed bacteria 
that were not present in the RBC membranes after contact with P. aeruginosa 
(Fig 4.2, B, lane 2). This was likely due to nonspecific binding of the antibodies to 
bacterial proteins. No proteins were detected in the sample containing RBC 
membranes that did not come in contact with P. aeruginosa (Fig 4.2, B, lane 3).  
 The antibodies used for detection were polyclonal and were developed 
using recombinant protein. These antibodies could be binding nonspecifically to 
other proteins. This is likely why, in some samples, other bands were detected in 
addition to the bands detected at the predicted molecular weights of PopB and 
PopD. Using monoclonal antibodies developed against the native translocators 
would minimize this nonspecific binding.  
PopD and PopB were detected on RBC membranes only after contact 
with the bacteria. These results suggest that P. aeruginosa inserted the 
translocon into the RBC membranes. 
4.3.2 Detection of translocon obtained from RBC membranes on BN-PAGE 
The translocon on RBC membranes was solubilized in detergent (DDM) 
and separated on a BN-PAGE. A sample solubilized in 1% SDS was included as 
a control, since 1% SDS is predicted to completely dissociate the translocon 
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complex into monomers (Montagner et al., 2011). Several bands were stained 
with Coomassie (Fig 4.3), since RBC membranes contain many membrane 
proteins that were likely isolated along with the translocons. The 3-20% gradient 
gels could only separate protein complexes with molecular weights lower than 
~500 kDa. The predicted molecular weight of the heterocomplex is 601 kDa. This 
could explain why a lot of protein remained in the wells.  
A western blot was performed to detect the translocator proteins PopB 
and PopD (Fig 4.4). PopD was detected in RBC membranes solubilized in 3.5% 
DDM and 1% SDS (Fig 4.4, A, lanes 1 and 7). A very faint band of PopB was 
detected in the lane containing RBC membranes solubilized 1% SDS (Fig 4.4, B, 
lane 7), however no PopB was detected in the lane containing RBC membranes 
solubilized in 3.5% DDM (Fig 4.4, B, lane 1). It is possible that these bands do 
not contain the translocator proteins, since nonspecific binding of both anti-PopB 
and anti-PopD antibodies was seen in the previous western blots performed with 
these antibodies (Fig 4.2),  
The 3-20% gradient could only separate proteins up to 500 kDa; therefore 
the bands detected were likely dissociated translocon complexes. Furthermore, 
PopB and PopD bands did not migrate similarly, indicating that the translocon 
complex quaternary structure was not maintained. These results suggest that 
3.5% is too high of a concentration of DDM to maintain the quaternary structure 
of the translocon. It also is possible that the molecular weight of the translocon is 
less than predicted, and could therefore be separated by the 3-20% gradient gel 
used. Unfortunately, the molecular weight marker did not stain with Ponceau  
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Figure 4.3. Separation of translocon isolated from infected RBCs on BN-
PAGE with a 3-20% acrylamide gradient. After solubilizing in the indicated 
detergent (right), samples containing isolated translocons were run on a 4-20% 
gradient acrylamide (see Methods 4.4.3). Protein was detected by staining with 





Figure 4.4. Detecting PopB and PopD in the translocon isolated from RBCs 
after separating on a BN-PAGE. After solubilizing in the indicated detergent 
(right), samples containing isolated translocons were run on a 4-20% gradient 
acrylamide gel (see Methods 4.4.3). A western blot was performed to detect (A) 
PopD and (B) PopB. All lanes (excluding the control, lane 3) contain 30 μg of 
protein. Lane 3 contains a control sample containing 10 times the minimal 
amount of protein detected by the antibodies (A) 100 ng PopD, or (B) 10 ng 





after transferring to the PVDF membrane, so it was not possible to determine the 
molecular weights of these bands.  
Purified PopB and PopD were both detected in their respective control 
lanes, however the translocators migrated very differently (Fig 4.4, A and B, lane 
3). The BN-PAGE separates proteins by size, and no denaturing agent was 
added (Wittig et al., 2006). PopD likely aggregated and this aggregate migrated 
differently from monomeric PopD. In the future, purified translocator complexes 
should be reconstituted in membranes and solubilized with detergents before 
running on a BN-PAGE. 
The BN-PAGE was repeated with a 3-12% acrylamide gradient gel to 
allow for higher molecular weight complexes to be separated. Alternative 
detergents and detergent concentrations were selected to solubilize the 
membrane proteins to determine optimal conditions for solubilizing the 
translocon. The BN-PAGE was stained with silver rather than Coomassie. Silver 
staining is up to 100 times more sensitive than Coomassie (Chevallet et al., 
2006), and the marker was more easily visualized using this staining method. A 
western blot was performed to detect PopD. 
Unfortunately, there was a problem with the gel, which caused the inner 
lanes to run much faster than the outer lanes. Many proteins were detected by 
silver staining, indicating that proteins were entering the gel (Fig 4.5, A). The 
molecular weight marker ran differently in the 3-12% gradient gel, separating 
complexes as large as ~750 kDa. PopD was detected in all lanes at the top of the 
wells, indicating the translocon was not fully solubilized (Fig 4.5, B). PopD  
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Figure 4.5. Separation of translocon isolated from infected RBCs on BN-
PAGE with a 4-12% acrylamide gradient. After solubilizing in the indicated 
detergent (right), samples containing isolated translocon were run on a 4-12% 
gradient acrylamide gel (see Methods 4.4.3) Lanes 1-4 contain 30 μg of protein. 
Lanes 6-9 contain 60 μg of protein. Protein was detected by (A) staining with 
silver, or (B) transferring to a PVDF membrane and detecting for PopD. 
Approximate molecular weights are indicated at left. PopD was detected with a 







solubilized with DDM and SDS entered the gel (Fig 4.5, B, lanes 2 and 6), 
however these samples were run in duplicate on the gel and their duplicate 
samples did not enter the gel. This was likely due to the gel not running properly. 
Few conclusions can be drawn from this gel because it did not run properly, 
however the results indicate that the 3-12% acrylamide gradient is appropriate for 
isolating a 601 kDa complex, the predicted molecular weight of the membrane-
reconstituted heterocomplex.  
4.4 Methods 
4.4.1 Inducing P. aeruginosa-RBC contact  
 An overnight culture of PAK was performed in 100 mL LB.  Four 500 mL 
LB cultures were inoculated with 25 mL of the overnight culture. The cells were 
cultivated until they reached an OD600 of 1.10. Cultures were pooled before 
splitting into four tubes and centrifuging to pellet cells (3,220xg, 10 min, 37°C).  
Cell pellets were washed in 50 mL LB. Cell pellets were resuspended in a 
minimum volume of LB (~1 mL).  The number of bacteria present in each pellet 
was estimated using the formula OD600 1.0 = 6x108 cells/mL (C. Rossi, 
unpublished data).   
RBCs were isolated from sheep blood with sodium heparin as an 
anticoagulant (Innovative Research) by washing. Two hundred milliliters of sheep 
blood was split into 20 mL aliquots in 50 mL centrifuge tubes. To each aliquot, 30 
mM Tris-HCl, 150 mM NaCl, pH 7.4 was added to bring the volume to 45 mL.  
The solution was resuspended gently by pipetting and then centrifuged to pellet 
RBCs (500xg, 15 min, 4°C). This process was repeated three times or until the 
60 
supernatant appeared clear. Washed RBCs were pooled and counted using a 
cell counter. Protease inhibitors (Roche) were added to the RBCs. 
An appropriate amount of RBCs were added to the bacteria to attain an 
MOI of two. Bacteria were diluted in LB to maintain a 3:1 ratio by volume of 
RBCs to bacteria. Cell contact was induced using a protocol modified from 
Montagner et al., 2011. Cells were centrifuged (1,000xg, 10 min, 37°C) to induce 
cell contact. The pellet was incubated at 37°C for 10 minutes before 
resuspending by shaking (100 rpm) for 2 min at 37°C. This was repeated four 
times. 
The reaction was transferred to a 50 mL tube and centrifuged (1,500xg, 10 
min, 4°C) to pellet bacteria. A flotation assay was performed with the supernatant 
containing the lysed RBCs to isolate the RBC membranes. Flotation assays were 
set up in 50 mL tubes to which 7.5 mL lysed RBCs were added along with 7.5 g 
sucrose. The solution was vortexed gently to dissolve the sucrose, generating a 
60% sucrose solution. The solution was overlaid with 12 mL 50% sucrose in 50 
mM Tris-HCl, pH 7.4, followed by 10 mL of 25% sucrose solution in the same 
buffer. The samples were centrifuged at 15,000xg, 16 hours, 4°C.  The RBC 
membranes were collected between the 25% and 50% sucrose layers. 
 The RBC membranes were pelleted (45,000xg, 60 min, 4°C). The pellets 
were washed two times in 35 mL BN-PAGE sample buffer (50 mM Bis-Tris, 50 
mM 6-aminohexanoic acid, 1 mM EDTA, pH 7.2). The pellet was resuspended in 
a minimal volume of BN-PAGE sample buffer and the protein concentration was 
determined using a bicinchoninic acid (BCA) assay (Pierce). The membranes 
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were split into aliquots containing 400 μg of protein, and 10% glycerol was added 
before pelleting (100,000xg, 30 min, 4°C). Pellets were stored at -20°C for 
several weeks.  
4.4.2 Isolating the translocon from RBCs after contact with P. aeruginosa 
Infected RBC membrane pellets were thawed on ice. Detergent in BN-
PAGE sample buffer was added to the pellet. The pellet was resuspended gently 
by pipetting up and down. Pellets were solubilized on ice on a shaker (50 rpm), 
for one hour. When SDS or digitonin was used, pellets were solubilized at 4°C to 
prevent precipitation of the detergent. Insoluble material was pelleted (20,000xg, 
1 hour, 4°C). The supernatant contained the solubilized translocon as well as 
other solubilized membrane proteins from the RBCs. 
4.4.3 Separation of the translocon isolated from RBCs by BN-PAGE 
Solubilized translocons were prepared for BN-PAGE by adding 
Coomassie brilliant blue G250 in MilliQ water to a final concentration of 25% of 
that of the detergent (Schägger et al., 1994). Ten percent glycerol was added to 
the samples. A Bis-Tris 4-12% gradient gel (Genscript) was set up in a Bio-Rad 
Mini Proteon electrophoresis apparatus. Initially a Bis-Tris 3-20% gradient gel 
(Genscript) was used with poor separation of the complexes. Samples were 
loaded onto the gel along with 5 μL of the NativeMark molecular weight marker 
(Invitrogen). The cathode buffer contained 50 mM Bis-Tris, 50 mM Tricine, 0.02% 
Coomassie brilliant blue G250, pH 6.8, while the anode buffer contained 50 mM 
Bis-Tris, pH 6.8. The gel was run at 100 V at 4°C until the dye front reached one 
third of the way down the gel, after which the cathode buffer was switched to 50 
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mM Bis-Tris, 50 mM Tricine, 0.002% Coomassie brilliant blue G250, pH 6.8. The 
gel was run at 30 mA until the dye front reached the bottom of the gel. 
The gel was soaked in transfer buffer (25 mM Tris-HCl, 192 mM glycine, 
10% methanol, 0.01% SDS) for 20 minutes at 4°C to coat proteins in the gel with 
SDS (Montagner et al., 2011). The gel was then transferred to a PVDF 
membrane for 90 minutes at 350 mA using a Trans-Blot Mini Electrophoretic 
Transfer Cell (Bio-Rad). The membrane was blocked with 5% milk, 50 mM Tris, 
150 mM NaCl, 0.1% Tween 20, pH 7.2 (TBST) overnight. The membrane was 
then incubated with double the normal concentration of primary antibody (1:500 
anti-PopD or 1:37,500 anti-PopB in 2.5% milk TBST) for one hour on a shaker 
(50 rpm), 23°C. The membrane was then washed three times with TBST and 
incubated on a shaker as before. A 1:30,000 dilution of secondary antibody (anti-
rabbit conjugated to alkaline phosphatase) in 2.5% milk TBST was incubated 
with the membrane for 1 hour as before. The membrane was washed as before 
but with an additional wash in TBS to remove the Tween 20 detergent. Immun-
Star AP Substrate (Bio-Rad) was added to the membrane to develop. The 







 While P. aeruginosa translocators have been successfully reconstituted in 
model membranes (Romano et al., 2011), no studies have been performed to 
assess these complexes in relation to those formed during infection. A study of 
the reconstituted complexes along with those formed in host cell membranes was 
conducted. 
 Initially the membrane complexes were assessed in relation to the P. 
aeruginosa T3S complex protein, monomeric PcrV. It is likely that the oligomeric 
form is necessary to interact with the membrane bound translocator complex. 
Ideally, interaction with the oligomeric PcrV complex would be assayed, however 
PcrV oligomers were not available. The needle contains the PcrV complex and 
therefore was considered as an alternative source of PcrV oligomers, however 
the needles were difficult to purify. Further interaction studies were performed 
with live P. aeruginosa cells. Results from these experiments indicate that P. 
aeruginosa interacts more readily with the reconstituted heterocomplex than 
homo-oligomers of either translocator, however it is unclear whether this binding 
occurs through the T3S apparatus. From these studies, it is not clear whether the 
heterocomplex reconstituted in model membranes is functional for interaction 
with other components of the T3S system. 
 The translocon formed during infection was isolated. RBCs were 
successfully infected by induced contact with P. aeruginosa. The RBC 
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membranes were dissolved with detergent, and the translocator complexes were 
solubilized. While the size of the translocon isolated from RBC membranes could 
not be estimated, appropriate conditions for forming the translocons on RBCs, 
and appropriate conditions for solubilizing the translocon from RBC membranes 
were assessed.  
5.2  Future directions 
5.2.1 Does P. aeruginosa bind specifically to heterocomplexes 
reconstituted in model membranes? 
While it is clear that P. aeruginosa binds more readily to the 
heterocomplex, it is unclear whether the binding of P. aeruginosa to PopB and 
PopD homo-oligomers or heterocomplexes in model membranes is specific. 
Further experimentation comparing binding to different amounts of the 
heterocomplex and different amounts of both homo-oligomers, would help 
determine if homo-oligomer binding is specific. Furthermore, reconstituting other 
irrelevant membrane proteins in the membranes would determine if P. 
aeruginosa binds nonspecifically to protein on membranes. 
5.2.2 Does P. aeruginosa binding to heterocomplexes reconstituted in 
model membranes occur through the T3S apparatus? 
To confirm interactions are specific to the T3S apparatus, the experiment 
described in 3.2.3 must be repeated with a PAKΩPopD strain in place of PAK. 
This would allow for the comparison of binding between cells that do not produce 
the T3S apparatus, and those that do, without secreting additional translocators 
that affect binding to liposomes. Furthermore, this experiment should also include 
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a sample containing only PopB homo-oligomers. This would allow for comparison 
to binding with the heterocomplex, since homo-oligomers are present when 
forming the heterocomplex (Romano et al., submitted).  
5.2.3 Utilizing a P. aeruginosa mutant that does not secrete 
phospholipases  
P. aeruginosa secretes effector proteins through the T3S system. These 
effectors are translocated through the translocon pore into the host cell. One of 
the effectors (ExoU) functions as a phospholipase (Sato and Frank, 2004). It is 
possible that this effector is secreted, degrading the liposomes. If a specific 
interaction occurred between the cell and the heterocomplex, this could stimulate 
secretion of this component. It is also possible that induction of T3S by low 
calcium could stimulate secretion of this phospholipase. By not stimulating T3S, 
secretion of this phospholipase would be minimized, however fewer T3S 
apparatuses will be produced (Mueller et al., 2005). To overcome this, a mutant 
strain that does not produce this effector could be used for this experiment. 
5.2.4 Isolate the translocon from infected epithelial cells 
Translocators have been detected on epithelial cells following infection 
with P. aeruginosa (Y. Tang, unpublished data). Since epithelial cells are the 
targets of P. aeruginosa infections in humans, it would be interesting to compare 
these translocons to those isolated from RBCs. The translocon could be isolated 
from the cell membranes using methods similar to those used for isolation from 
RBCs. Less translocons will be obtained, as infections cannot be performed 
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easily with a large amount of epithelial cells as can be done with RBCs. To 
overcome this, the translocons could be purified as described below. 
5.2.4.1 Purification of the translocon from membranes  
After solubilizing the membranes, the translocon could be isolated from 
other solubilized membrane proteins using chromatography. It is possible to add 
a tag to isolate the translocon from other complexes efficiently (Montagner et al., 
2011). This would allow for translocons to be concentrated, allowing the 
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